Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study

被引：1
|
作者：
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don A.
Trevarthen, David
Giurescu, Marius
Kupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT149
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Copanlisib monotherapy activity in relapsed or refractory indolent B-cell lymphoma: Combined analysis from phase I and II studies
    Zinzani, P. L.
    Santoro, A.
    Mollica, L.
    Follows, G. A.
    Bouabdallah, K.
    Morschhauser, F.
    Patnaik, A.
    Huang, L.
    Hiemeyer, F.
    Benson, A.
    Genvresse, I.
    Garcia-Vargas, J. E.
    Childs, B. H.
    Dreyling, M. H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
    Qingyuan Zhang
    Rong Tao
    Zhenyu Li
    Haiyi Guo
    Meng Ji
    Lu Zhang
    Jane Huang
    Fu Lina
    Jinhua Zhong
    Jianfeng Zhou
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2503 - 2506
  • [23] Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
    Thieblemont, Catherine
    Phillips, Tycel
    Ghesquieres, Herve
    Cheah, Chan Y.
    Clausen, Michael Roost
    Cunningham, David
    Do, Young Rok
    Feldman, Tatyana
    Gasiorowski, Robin
    Jurczak, Wojciech
    Kim, Tae Min
    Lewis, David John
    van der Poel, Marjolein
    Poon, Michelle Limei
    Doerr, Thomas
    Kilavuz, Nurgul
    Chen, Menghui
    Sacchi, Mariana
    Elliott, Brian
    Hutchings, Martin
    Lugtenburg, Pieternella
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S379 - S379
  • [24] Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
    Lenz, Georg
    Hawkes, Eliza
    Verhoef, Gregor
    Haioun, Corinne
    Thye, Lim Soon
    Heo, Dae Seog
    Ardeshna, Kirit
    Chong, Geoffrey
    Christensen, Jacob Haaber
    Shi, Vivian
    Lippert, Susanne
    Niemeyer, Florian
    Piraino, Paolo
    Pena, Carol Elaine
    Buvaylo, Viktoriya
    Childs, Barrett H.
    Gorbatchevsky, Igor
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma
    Munakata, Wataru
    Shirasugi, Yukari
    Tobinai, Kensei
    Onizuka, Makoto
    Makita, Shinichi
    Suzuki, Rikio
    Maruyama, Dai
    Kawai, Hidetsugu
    Izutsu, Koji
    Nakanishi, Tadashi
    Shiba, Sari
    Hojo, Seichiro
    Ando, Kiyoshi
    CANCER SCIENCE, 2021, 112 (03) : 1123 - 1131
  • [26] Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
    H Saito
    D Maruyama
    A M Maeshima
    S Makita
    H Kitahara
    K Miyamoto
    S Fukuhara
    W Munakata
    T Suzuki
    Y Kobayashi
    H Taniguchi
    K Tobinai
    Blood Cancer Journal, 2015, 5 : e362 - e362
  • [27] Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
    Saito, H.
    Maruyama, D.
    Maeshima, A. M.
    Makita, S.
    Kitahara, H.
    Miyamoto, K.
    Fukuhara, S.
    Munakata, W.
    Suzuki, T.
    Kobayashi, Y.
    Taniguchi, H.
    Tobinai, K.
    BLOOD CANCER JOURNAL, 2015, 5 : e362 - e362
  • [28] A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ogura, Michinori
    Ando, Kiyoshi
    Suzuki, Tatsuya
    Ishizawa, Kenichi
    Oh, Sung Yong
    Itoh, Kuniaki
    Yamamoto, Kazuhito
    Au, Wing Yan
    Tien, Hwei-Fang
    Matsuno, Yoshihiro
    Terauchi, Takashi
    Yamamoto, Keiko
    Mori, Masahiko
    Tanaka, Yoshinobu
    Shimamoto, Takashi
    Tobinai, Kensei
    Kim, Won Seog
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 768 - 776
  • [29] Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma
    Di Bella, Nicholas
    Taetle, Raymond
    Kolibaba, Kathryn S.
    Boyd, Thomas E.
    Raju, Robert N.
    Barrera, David N.
    Cochran, Ernest
    Dien, Philip
    Hakimian, David
    Lyons, Roger M.
    Schlegel, Peter J.
    Vukelja, Svetislava J.
    Boston, Julie
    Boehm, Kristi A.
    Wang, Yunfei
    Asmar, Lina
    BLOOD, 2008, 112 (11) : 558 - 558
  • [30] Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma
    Di Bella, Nicholas
    Taetle, Raymond
    Kolibaba, Kathryn
    Boyd, Thomas
    Raju, Robert
    Barrera, David
    Cochran, Ernest W., Jr.
    Dien, Philip Y.
    Lyons, Roger
    Schlegel, Peter J.
    Vukelja, Svetislava J.
    Boston, Julie
    Boehm, Kristi A.
    Wang, Yunfei
    Asmar, Lina
    BLOOD, 2010, 115 (03) : 475 - 480
12345